United Health Products (United Health Products) Long-Term Capital Lease Obligation : $0.04 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is United Health Products Long-Term Capital Lease Obligation?

United Health Products's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.04 Mil.

United Health Products's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($0.06 Mil) to Dec. 2023 ($0.05 Mil) and declined from Dec. 2023 ($0.05 Mil) to Mar. 2024 ($0.04 Mil).

United Health Products's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.05 Mil).

United Health Products Long-Term Capital Lease Obligation Historical Data

The historical data trend for United Health Products's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Health Products Long-Term Capital Lease Obligation Chart

United Health Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.05

United Health Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	0.07	0.06	0.05	0.04

United Health Products (OTCPK:UEEC) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

United Health Products Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of United Health Products's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

United Health Products (United Health Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

526 Commerce Circle, Suite No. 120, Mesquite, NV, USA, 89027

Website

https://www.uhpcorp.com

United Health Products Inc is a US-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.

Executives

Brian David Thom	officer: CEO	10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton	officer: Vice-President Finance, CFO	526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight	director	C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro	officer: Chief Operating Officer	10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate	officer: CEO
Robert J. Denser	director	10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto	director	1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus	director
Rodney Paul Leibowitz	director	420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik	director	11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh	director	2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman	director, officer: President, Chairman and CEO	1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason	director, officer: Chief Financial Officer	120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel	director, officer: Chief Executive Officer	1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan	10 percent owner	3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445